Effect of gemfibrozil ± niacin ± cholestyramine on endothelial function in patients with serum low-density lipoprotein cholesterol levels < 160 mg/dl and high-density lipoprotein cholesterol levels < 40 mg/dl

American Journal of Cardiology

Volumn 80, Issue 7, 1997, Pages 831-835

  Andrews, Thomas C ^a   Whitney, Edwin J ^a   Green, Garfield ^a   Kalenian, Robert ^a   Personius, Bradley E ^a  

^a WILFORD HALL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLESTYRAMINE; GEMFIBROZIL; NICOTINIC ACID; ANTILIPEMIC AGENT;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD FLOW VELOCITY; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VASCULAR ENDOTHELIUM; BRACHIAL ARTERY; CORONARY ARTERY DISEASE; DRUG COMBINATION; HYPERLIPIDEMIA; MIDDLE AGED; PATHOPHYSIOLOGY; REFERENCE VALUE; VASODILATATION;

AGED; ANTILIPEMIC AGENTS; BRACHIAL ARTERY; CHOLESTYRAMINE; CORONARY DISEASE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ENDOTHELIUM, VASCULAR; FEMALE; GEMFIBROZIL; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MIDDLE AGED; NIACIN; REFERENCE VALUES; VASODILATION;

EID: 0030612713     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00531-6     Document Type: Article

References (16)

1. Leung W-H, Lau C-P, Wong C-K. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients. Lancet. 341:1993;1496-1500.
2. Anderson T, Meredith I, Yeung A, Frei B, Selwyn A, Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med. 332:1995;488-493.
3. Treasure C, Klein J, Weintraub W, Talley J, Stillabower M, Kosinski A, Zhang J, Boccuzzi S, Cedarholm J, Alexander R. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med. 332:1995;481-487.
4. Egashira K, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Inou T, Takeshita A. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation. 89:1994;2519-2524.
5. Sorensen K, Celermajer D, Georgakopoulos D, Hatcher G, Betteridge D, Deanfield J. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoproein (a) level. J Clin Invest. 93:1994;50-55.
6. Celermajer D, Sorensen K, Gooch V, Spiegelhalter D, Miller O, Sullivan I, Lloyd J, Deanfield J. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 340:1992;1111-1115.
7. Celermajer D, Sorensen K, Georgakopoulos D, Bull C, Thomas O, Robinson J, Deanfield J. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation. 88:1993;2149-2155.
8. Celermajer D, Sorensen K, Ryalls M, Robinson J, Thomas O, Leonard J, Deanfield J. Impaired endothelial function occurs in the systemic arteries of children with homozygous homocystinuria but not in their heterozygous parents. J Am Coll Cardiol. 22:1993;854-858.
9. Celermajer D, Sorensen K, Bull C, Robinson J, Deanfield J. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol. 24:1994;1468-1474.
10. Joannides R, Haefeli W, Linder L, Richard V, Bakkali E, Thuillez C, Luscher T. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation. 91:1995;1314-1319.
11. Anderson T, Uehata A, Gerhard M, Meredith I, Knab S, Delagrange D, Lieberman E, Ganz P, Creager M, Yeung A, Selwyn A. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol. 26:1995;1235-1241.
12. Brush JJ, Faxon D, Salmon S, Jacobs A, Ryan T. Abnormal endothelium-dependent coronary vasomotion in hypertensive patients. J Am Coll Cardiol. 19:1992;809-815.
13. Panza J, Casino P, Kilcoyne C, Quyyumi A. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation. 87:1993;1468-1474.
14. Panza J, Quyyumi A, Callahan T, Epstein S. Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension. J Am Coll Cardiol. 21:1993;1145-1151.
15. Sorensen K, Kristensen I, Celermajer D. Atherosclerosis in the human brachial artery. J Am Coll Cardiol. 29:1997;318-322.
16. Corretti M, Plotnick G, Vogel R. Technical aspects of evaluating brachial artery vasodilatation using high-frequency ultrasound. Am J Physiol. 268:1995;H1397-H1404.